Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Frey, KA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 124 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Suzuki, M; Desmond, TJ; Albin, RL; Frey, KA
      Vesicular neurotransmitter transporters in Huntington's disease: Initial observations and comparison with traditional synaptic markers

      SYNAPSE
    2. Zubieta, JK; Koeppe, AR; Frey, KA; Kilbourn, MR; Mangner, TJ; Foster, NL; Kuhl, DE
      Assessment of muscarinic receptor concentrations in affinity and Alzheimerdisease with [C-11]NMPB and PET

      SYNAPSE
    3. Minoshima, S; Foster, NL; Sima, AAF; Frey, KA; Albin, RL; Kuhl, DE
      Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation

      ANNALS OF NEUROLOGY
    4. Frey, KA
      The neurochemistry of therapeutics: Levodopa pharmacodynamics in Parkinson's disease

      ANNALS OF NEUROLOGY
    5. Kuhl, DE; Minoshima, S; Frey, KA; Foster, NL; Kilbourn, MR; Koeppe, RA
      Central acetylcholinesterase inhibition in Alzheimer patients - Reply

      ANNALS OF NEUROLOGY
    6. Zubieta, JK; Taylor, SF; Huguelet, P; Koeppe, RA; Kilbourn, MR; Frey, KA
      Vesicular monoamine transporter concentrations in bipolar disorder type I,schizophrenia, and healthy subjects

      BIOLOGICAL PSYCHIATRY
    7. Shekhar, A; McCann, UD; Meaney, MJ; Blanchard, DC; Davis, M; Frey, KA; Liberzon, I; Overall, KL; Shear, MK; Tecott, LH; Winsky, L
      Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders

      PSYCHOPHARMACOLOGY
    8. Taylor, SF; Koeppe, RA; Tandon, R; Zubieta, JK; Frey, KA
      In vivo measurement of the vesicular monoamine transporter in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    9. Frey, KA
      Neuroimaging in neurotoxicology

      NEUROLOGIC CLINICS
    10. Kuhl, DE; Minoshima, S; Frey, KA; Foster, NL; Kilbourn, MR; Koeppe, RA
      Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex

      ANNALS OF NEUROLOGY
    11. Albin, RL; Koeppe, RA; Chervin, RD; Consens, FB; Wernette, K; Frey, KA; Aldrich, MS
      Decreased striatal dopaminergic innervation in REM sleep behavior disorder

      NEUROLOGY
    12. Bohnen, NI; Koeppe, RA; Meyer, P; Ficaro, E; Wernette, K; Kilbourn, MR; Kuhl, DE; Frey, KA; Albin, RL
      Decreased striatal monoaminergic terminals in Huntington disease

      NEUROLOGY
    13. Skaddan, MB; Kilbourn, MR; Snyder, SE; Sherman, PS; Desmond, TJ; Frey, KA
      Synthesis, F-18-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors

      JOURNAL OF MEDICINAL CHEMISTRY
    14. Cowell, RM; Kantor, L; Hewlett, GHK; Frey, KA; Gnegy, ME
      Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Zubieta, JK; Huguelet, P; Ohl, LE; Koeppe, RA; Kilbourn, MR; Carr, JM; Giordani, BJ; Frey, KA
      High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: Sex differences and cognitive correlates

      AMERICAN JOURNAL OF PSYCHIATRY
    16. Snyder, SE; Sherman, PS; Desmond, TJ; Frey, KA; Kilbourn, MR
      (-)-6 ',7 '-[C-11]dihydroroten-12 alpha-ol ((-)-[C-11]DHROL) for in vivo measurement of mitochondrial complex I

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    17. Koeppe, RA; Frey, KA; Kuhl, DE; Kilbourn, MR
      Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [C-11]dihydrotetrabenazine

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    18. Koeppe, RA; Frey, KA; Snyder, SE; Meyer, P; Kilbourn, MR; Kuhl, DE
      Kinetic modeling of N-[C-11]methylpiperidin-4-yl propionate: Alternatives for analysis of an irreversible positron emission tomography tracer for measurement of acetylcholinesterase activity in human brain

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    19. Meyer, P; Bohnen, NI; Minoshima, S; Koeppe, RA; Wernette, K; Kilbourn, MR; Kuhl, DE; Frey, KA; Albin, RL
      Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome

      NEUROLOGY
    20. Bohnen, NI; Albin, RL; Frey, KA; Fink, JK
      (+)-alpha-[C-11]dihydro-tetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis

      NEUROLOGY
    21. Kuhl, DE; Koeppe, RA; Minoshima, S; Snyder, SE; Ficaro, EP; Foster, NL; Frey, KA; Kilbourn, MR
      In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

      NEUROLOGY
    22. Bohnen, NI; Minoshima, S; Giordani, B; Frey, KA; Kuhl, DE
      Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia

      NEUROLOGY
    23. Pennell, PB; Burdette, DE; Ross, DA; Henry, TR; Albin, RL; Sackellares, JC; Frey, KA
      Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis

      EPILEPSIA
    24. Little, KY; Zhang, L; Desmond, T; Frey, KA; Dalack, GW; Cassin, BJ
      Striatal dopaminergic abnormalities in human cocaine users

      AMERICAN JOURNAL OF PSYCHIATRY
    25. Frey, KA; Minoshima, S; Kuhl, DE
      Neurochemical imaging of Alzheimer's disease and other degenerative dementias

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    26. MULHOLLAND GK; WIELAND DM; KILBOURN MR; FREY KA; SHERMAN PS; CAREY JE; KUHL DE
      [F-18] FLUOROETHOXY-BENZOVESAMICOL, A PET RADIOTRACER FOR THE VESICULAR ACETYLCHOLINE TRANSPORTER AND CHOLINERGIC SYNAPSES

      Synapse
    27. KEARNEY JAF; BECKER JB; FREY KA; ALBIN RL
      THE ROLE OF NIGROSTRIATAL DOPAMINE IN METABOTROPIC GLUTAMATE AGONIST-INDUCED ROTATION

      Neuroscience
    28. ZUBIETA JK; KOEPPE RA; MULHOLLAND GK; KUHL DE; FREY KA
      QUANTIFICATION OF MUSCARINIC CHOLINERGIC RECEPTORS WITH [C-11] NMPB AND POSITRON-EMISSION-TOMOGRAPHY - METHOD DEVELOPMENT AND DIFFERENTIATION OF TRACER DELIVERY FROM RECEPTOR-BINDING

      Journal of cerebral blood flow and metabolism
    29. FREY KA; BOHNEN NI; MEYER P; MINOSHIMA S; WERNETTE K; KOEPPE RA; KILBOURN MR; KUHL DE
      PRESYNAPTIC MONOAMINERGIC VESICLES IN NORMAL AGING STUDIED BY (-[C-11]DTBZ PET())

      The Journal of nuclear medicine
    30. BOHNEN NI; MEYER P; ALBIN RL; MINOSHIMA S; WERNETTE K; KOEPPE RA; KILBOURN MR; KUHL DE; FREY KA
      CLINICAL CORRELATES OF STRIATAL (-[C-11]DTBZ BINDING TO VMAT2 IN PARKINSONS-DISEASE())

      The Journal of nuclear medicine
    31. MINOSHIMA S; GIORDANI B; BERENT S; FREY KA; FOSTER NL; KUHL DE
      [F-18] FDG PET PREDICTS THE DEVELOPMENT OF ALZHEIMERS-DISEASE IN MEMORY-IMPAIRED PATIENTS WITHOUT DEMENTIA

      The Journal of nuclear medicine
    32. BOHNEN NI; MEYER P; KOEPPE RA; KILBOURN MR; KUHL DE; FREY KA; ALBIN RL
      DECREASED STRIATAL MONOAMINERGIC TERMINALS IN HUNTINGTONS-DISEASE DEMONSTRATED WITH (-[C-11]DTBZ PET())

      The Journal of nuclear medicine
    33. MEYER P; BOHNEN NI; MINOSHIMA S; WERNETTE K; KOEPPE RA; KILBOURN MR; KUHL DE; FREY KA; ALBIN RL
      PRESYNAPTIC MONOAMINERGIC VESICLES IN TOURETTE-SYNDROME STUDIED BY (-[C-11]DTBZ PET())

      The Journal of nuclear medicine
    34. FREY KA; BOHNEN NI; MEYER P; ELMER L; ALBIN RL; KOEPPE RA; KILBOURN MR; KUHL DE
      (-[C-11]DTBZ PET IMAGING OF PRESYNAPTIC MONOAMINERGIC VESICLES IN ISOLATED POSTURAL TREMOR())

      The Journal of nuclear medicine
    35. ROSE DS; MINOSHIMA S; NISHIMURA S; FREY KA; YOUNG S; KUHL DE
      AGE-ADJUSTED NORMAL IMAGE DATABASE FOR THE INTERPRETATION OF FUNCTIONAL BRAIN IMAGES

      The Journal of nuclear medicine
    36. MINOSHIMA S; FREY KA; KUHL DE
      CEREBELLAR METABOLIC REDUCTION IN ALZHEIMERS-DISEASE AND DATA NORMALIZATION

      The Journal of nuclear medicine
    37. BOHNEN NI; MINOSHIMA S; GIORDANI B; ROSE DS; FREY KA; KUHL DE
      PRECLINICAL EVIDENCE OF DEMENTIA IN PATIENTS WITH MILD-TO-MODERATE PARKINSONS-DISEASE STUDIED BY [18F]FLUORODEOXYGLUCOSE (FDG) POSITRON-EMISSION-TOMOGRAPHY

      Neurology
    38. TAYLOR SF; TANDON R; ZUBIETA JK; HUGUELET P; FREY KA
      IN-VIVO MEASUREMENT OF PRESYNAPTIC DOPAMINE INNERVATION IN SCHIZOPHRENIA

      Biological psychiatry
    39. ZUBIETA JK; HUGUELET P; OHL LE; KILBOURN MR; KOEPPE RA; FREY KA
      PET MEASURES OF MONOAMINERGIC SYNAPTIC DENSITY IN BIPOLAR-I DISORDER - RELATIONSHIP WITH AGE-OF-ONSET

      Biological psychiatry
    40. KIM B; BOES JL; FREY KA; MEYER CR
      MUTUAL INFORMATION FOR AUTOMATED UNWARPING OF RAT-BRAIN AUTORADIOGRAPHS

      NeuroImage
    41. TURNER RS; CERVIN RD; FREY KA; MINOSHIMA S; KUHL DE
      PROBABLE DIFFUSE LEWY BODY DISEASE PRESENTING AS RAPID EYE-MOVEMENT SLEEP BEHAVIOR DISORDER

      Annals of neurology
    42. MINOSHIMA S; GIORDANI B; BERENT S; FREY KA; FOSTER NL; KUHL DE
      METABOLIC REDUCTION IN THE POSTERIOR CINGULATE CORTEX IN VERY EARLY ALZHEIMERS-DISEASE

      Annals of neurology
    43. DWAMENA BA; BELCHER KK; DASIKA N; FREY KA
      FOCAL HYPEREMIA ON RBC BLOOD-FLOW IMAGING - A SCINTIGRAPHIC MARKER OFARTERIOPORTAL VENOUS SHUNTING IN HEPATIC CAVERNOUS HEMANGIOMAS

      Clinical nuclear medicine
    44. KOEPPE RA; FREY KA; KUME A; ALBIN R; KILBOURN MR; KUHL DE
      EQUILIBRIUM VERSUS COMPARTMENTAL ANALYSIS FOR ASSESSMENT OF THE VESICULAR MONOAMINE TRANSPORTER USING (-ALPHA-[C-11]DIHYDROTETRABENAZINE (DTBZ) AND POSITRON-EMISSION-TOMOGRAPHY())

      Journal of cerebral blood flow and metabolism
    45. KILBOURN MR; CHARALAMBOUS A; FREY KA; SHERMAN P; HIGGINS DS; GREENAMYRE JT
      INTRASTRIATAL NEUROTOXIN INJECTIONS REDUCE IN-VITRO AND IN-VIVO BINDING OF RADIOLABELED ROTENOIDS TO MITOCHONDRIAL COMPLEX-I

      Journal of cerebral blood flow and metabolism
    46. MACDONALD GA; FREY KA; AGRANOFF BW; MINOSHIMA S; KOEPPE RA; KUHL DE; SHULKIN BL; LUCEY MR
      CEREBRAL BENZODIAZEPINE RECEPTOR-BINDING IN-VIVO IN PATIENTS WITH RECURRENT HEPATIC-ENCEPHALOPATHY

      Hepatology
    47. KEARNEY JAF; FREY KA; ALBIN RL
      METABOTROPIC GLUTAMATE AGONIST-INDUCED ROTATION - A PHARMACOLOGICAL, FOS IMMUNOHISTOCHEMICAL, AND [C-14] 2-DEOXYGLUCOSE AUTORADIOGRAPHIC STUDY

      The Journal of neuroscience
    48. MINOSHIMA S; FOSTER NL; FREY KA; WAHL RL; BURDETTE JH; KUHL DE
      CAN FDG PET DISTINGUISH DEMENTIA PATIENTS WITH CORTICAL LEWY BODIES FROM PURE ALZHEIMERS-DISEASE

      The Journal of nuclear medicine
    49. BOHNEN NI; MINOSHIMA S; GIORDANI B; FREY KA; KUHL DE
      CLINICAL CORRELATES OF OCCIPITAL HYPOMETABOLISM IN PARKINSONS-DISEASE

      The Journal of nuclear medicine
    50. FREY KA; KOEPPE RA; KILBOURN MR; SNYDER SE; KUHL DE
      PET QUANTIFICATION OF CORTICAL ACETYLCHOLINESTERASE INHIBITION IN MONKEY AND HUMAN

      The Journal of nuclear medicine
    51. KOEPPE RA; FREY KA; SNYDER SE; KILBOURN MR; KUHL DE
      KINETIC-ANALYSIS ALTERNATIVES FOR ASSESSING ACHE ACTIVITY WITH N-[C-11]METHYLPIPERIDINYL PROPIONATE (PMP) - TO CONSTRAIN OR NOT TO CONSTRAIN

      The Journal of nuclear medicine
    52. VANDERBORGHT T; MINOSHIMA S; GIORDANI B; FOSTER NL; FREY KA; BERENT S; ALBIN RL; KOEPPE RA; KUHL DE
      CEREBRAL METABOLIC DIFFERENCES IN PARKINSONS AND ALZHEIMERS-DISEASES MATCHED FOR DEMENTIA SEVERITY

      The Journal of nuclear medicine
    53. TURNER RS; CHERVIN RD; FREY KA; MINOSHIMA S; KUHL DE
      PROBABLE DIFFUSE LEWY BODY DISEASE PRESENTING AS REM-SLEEP BEHAVIOR DISORDER

      Neurology
    54. SCHWARZ RD; NELSON CB; AUGELLISZAFRAN CE; PENVOSE JR; JAEN JC; WILEY J; FREY KA
      PHARMACOLOGICAL CHARACTERIZATION OF PD182807 - AN M4 SUBTYPE-SELECTIVE MUSCARINIC ANTAGONIST

      Life sciences
    55. KILBOURN MR; FREY KA; VANDERBORGHT T; SHERMAN PS
      EFFECTS OF DOPAMINERGIC DRUG TREATMENTS ON IN-VIVO RADIOLIGAND BINDING TO BRAIN VESICULAR MONOAMINE TRANSPORTERS

      Nuclear medicine and biology
    56. FREY KA; KOEPPE RA; KILBOURN MR; VANDERBORGHT TM; ALBIN RL; GILMAN S; KUHL DE
      PRESYNAPTIC MONOAMINERGIC VESICLES IN PARKINSONS-DISEASE AND NORMAL AGING

      Annals of neurology
    57. GILMAN S; FREY KA; KOEPPE RA; JUNCK L; LITTLE R; VANDERBORGHT TM; LOHMAN M; MARTORELLO S; LEE LC; JEWETT DM; KILBOURN MR
      DECREASED STRIATAL MONOAMINERGIC TERMINALS IN OLIVOPONTOCEREBELLAR ATROPHY AND MULTIPLE SYSTEM ATROPHY DEMONSTRATED WITH POSITRON EMISSION TOMOGRAPHY

      Annals of neurology
    58. KUHL DE; MINOSHIMA S; FESSLER JA; FREY KA; FOSTER NL; FICARO EP; WIELAND DM; KOEPPE RA
      IN-VIVO MAPPING OF CHOLINERGIC TERMINALS IN NORMAL AGING, ALZHEIMERS-DISEASE, AND PARKINSONS-DISEASE

      Annals of neurology
    59. BUCK A; MULHOLLAND GK; PAPADOPOULOS SM; KOEPPE RA; FREY KA
      KINETIC EVALUATION OF POSITRON-EMITTING MUSCARINIC RECEPTOR LIGANDS EMPLOYING DIRECT INTRACAROTID INJECTION

      Journal of cerebral blood flow and metabolism
    60. KOEPPE RA; FREY KA; VANDERBORGHT TM; KARLAMANGLA A; JEWETT DM; LEE LC; KILBOURN MR; KUHL DE
      KINETIC EVALUATION OF [C-11] DIHYDROTETRABENAZINE BY DYNAMIC PET - MEASUREMENT OF VESICULAR MONOAMINE TRANSPORTER

      Journal of cerebral blood flow and metabolism
    61. FREY KA; MINOSHIMA S; KOEPPE RA; KILBOURN MR; BERGER KL; KUHL DE
      STEREOTAXIC SUMMATION ANALYSIS OF HUMAN CEREBRAL BENZODIAZEPINE BINDING MAPS

      Journal of cerebral blood flow and metabolism
    62. LEE KS; FREY KA; KOEPPE RA; BUCK A; MULHOLLAND GK; KUHL DE
      IN-VIVO QUANTIFICATION OF CEREBRAL MUSCARINIC RECEPTORS IN NORMAL HUMAN AGING USING POSITRON EMISSION TOMOGRAPHY AND [C-11] TROPANYL BENZILATE

      Journal of cerebral blood flow and metabolism
    63. BROWN RS; LEUNG JY; FISHER SJ; FREY KA; ETHIER SP; WAHL RL
      INTRATUMORAL DISTRIBUTION OF TRITIATED-FDG IN BREAST-CARCINOMA - CORRELATION BETWEEN GLUT-1 EXPRESSION AND FDG UPTAKE

      The Journal of nuclear medicine
    64. KUHL DE; KOEPPE RA; SNYDER SE; MINOSHIMA S; FREY KA; KILBOURN MR
      MAPPING ACETYLCHOLINESTERASE IN HUMAN BRAIN USING PET AND N-[C-11]METHYLPIPERIDINYL PROPIONATE (PMP)

      The Journal of nuclear medicine
    65. KOEPPE RA; FREY KA; JEWETT DM; KILBOURN MR; KUHL DE
      EQUILIBRIUM VERSUS COMPARTMENTAL ANALYSIS FOR ASSESSMENT OF THE VESICULAR MONOAMINE TRANSPORTER USING (-ALPHA-[C-11]DIHYDROTETRABENAZINE (DTBZ) AND PET())

      The Journal of nuclear medicine
    66. MINOSHIMA S; GIORDANI BL; BERENT S; FREY KA; FOSTER NL; KUHL DE
      THE POSTERIOR CINGULATE CORTEX - THE EARLIEST METABOLIC REDUCTION IN ALZHEIMERS-DISEASE AS REVEALED BY PET

      The Journal of nuclear medicine
    67. MINOSHIMA S; FREY KA; GIORDANI BL; FOSTER NL; KOEPPE RA; BERENT S; ALBIN RL; KUHL DE
      TECHNICAL FEASIBILITY AND INITIAL DIAGNOSTIC APPLICATION OF FUNCTIONAL BRAIN IMAGE DATABASE SYSTEM IN DEMENTIA

      The Journal of nuclear medicine
    68. FREY KA; MURMAN DL; MINOSHIMA S; FOSTER NL; BUCHTEL HA; KUHL DE
      DIAGNOSTIC EVALUATION OF [F-18] FDG PET SCANNING IN PATIENTS UNDERGOING EVALUATION FOR DEMENTIA

      The Journal of nuclear medicine
    69. MURPHY KJ; DEVEIKIS JP; JAMADAR DA; BRUNBERG JA; DICKINSON LD; FREY KA
      15 H2O PET DETERMINATION OF CEREBRAL BLOOD-FLOW AFTER INTRAVENOUS ACETAZOLAMIDE DURING BALLOON TEST OCCLUSION OF THE INTERNAL CAROTID-ARTERY

      Radiology
    70. MEYER CR; BOES JL; KIM B; FREY KA; WAHL RL
      AUTOMATIC MULTIMODALITY GRAY-SCALE REGISTRATION THROUGH MUTUAL INFORMATION

      Radiology
    71. ALBIN RL; MINOSHIMA S; DAMATO CJ; FREY KA; KUHL DA; SIMA AAF
      FLUORO-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN DIFFUSE LEWY BODYDISEASE

      Neurology
    72. JUNG YW; FREY KA; MULHOLLAND GK; DELROSARIO R; SHERMAN PS; RAFFEL DM; VANDORT ME; KUHL DE; GILDERSLEEVE DL; WIELAND DM
      VESAMICOL RECEPTOR MAPPING OF BRAIN CHOLINERGIC NEURONS WITH RADIOIODINE-LABELED POSITIONAL ISOMERS OF BENZOVESAMICOL

      Journal of medicinal chemistry
    73. LEE LC; VANDERBORGHT TV; SHERMAN PS; FREY KA; KILBOURN MR
      IN-VITRO AND IN-VIVO STUDIES OF BENZISOQUINOLINE LIGANDS FOR THE BRAIN SYNAPTIC VESICLE MONOAMINE TRANSPORTER

      Journal of medicinal chemistry
    74. CHARALAMBOUS A; TLUCZEK L; FREY KA; HIGGINS DS; GREENAMYRE TJ; KILBOURN MR
      SYNTHESIS AND BIOLOGICAL EVALUATION IN MICE OF (2-[C-11]METHOXY)-6',7'-DIHYDROROTENOL, A 2ND GENERATION ROTENOID FOR MARKING MITOCHONDRIAL COMPLEX-I ACTIVITY

      Nuclear medicine and biology
    75. MULHOLLAND GK; KILBOURN MR; SHERMAN P; CAREY JE; FREY KA; KOEPPE RA; KUHL DE
      SYNTHESIS, IN-VIVO BIODISTRIBUTION AND DOSIMETRY OF [C-11] N-METHYLPIPERIDYL BENZILATE ([C-11]NMPB), A MUSCARINIC ACETYLCHOLINE-RECEPTOR ANTAGONIST

      Nuclear medicine and biology
    76. MINOSHIMA S; FREY KA; FOSTER NL; KUHL DE
      PRESERVED PONTINE GLUCOSE-METABOLISM IN ALZHEIMER-DISEASE - A REFERENCE REGION FOR FUNCTIONAL BRAIN IMAGE (PET) ANALYSIS

      Journal of computer assisted tomography
    77. VANDERBORGHT TM; SIMA AAF; KILBOURN MR; DESMOND TJ; KUHL DE; FREY KA
      [H-3] METHOXYTETRABENAZINE - A HIGH SPECIFIC ACTIVITY LIGAND FOR ESTIMATING MONOAMINERGIC NEURONAL INTEGRITY

      Neuroscience
    78. MINOSHIMA S; FREY KA; KOEPPE RA; FOSTER NL; KUHL DE
      A DIAGNOSTIC-APPROACH IN ALZHEIMERS-DISEASE USING 3-DIMENSIONAL STEREOTAXIC SURFACE PROJECTIONS OF FLUORINE-18-FDG PET

      The Journal of nuclear medicine
    79. GROOM GN; JUNCK L; FOSTER NL; FREY KA; KUHL DE
      PET OF PERIPHERAL BENZODIAZEPINE BINDING-SITES IN THE MICROGLIOSIS OFALZHEIMERS-DISEASE

      The Journal of nuclear medicine
    80. VANDERBORGHT TM; KILBOURN MR; KOEPPE RA; DASILVA JN; CAREY JE; KUHL DE; FREY KA
      IN-VIVO IMAGING OF THE BRAIN VESICULAR MONOAMINE TRANSPORTER

      The Journal of nuclear medicine
    81. BROWN RS; LEUNG JY; FISHER SJ; FREY KA; ETHIER SP; WAHL RL
      INTRATUMORAL DISTRIBUTION OF TRITIATED FLUORODEOXYGLUCOSE IN BREAST-CARCINOMA .1. ARE INFLAMMATORY CELLS IMPORTANT

      The Journal of nuclear medicine
    82. KIM B; BOES BJ; FREY KA; MUKHOPADHYAY SK; ROSS BD; MEYER CR
      AFFINE VERSUS WARPING IN COREGISTRATION OF MR-IMAGING AND AUTORADIOGRAPHY

      Radiology
    83. BURDETTE DE; SAKURAI SY; HENRY TR; ROSS DA; PENNELL PB; FREY KA; SACKELLARES JC; ALBIN RL
      TEMPORAL-LOBE CENTRAL BENZODIAZEPINE BINDING IN UNILATERAL MESIAL TEMPORAL-LOBE EPILEPSY

      Neurology
    84. CHEN R; ROTHSTEIN JD; FREY KA; TEVAARWERK GJ; HAHN AF
      IDIOPATHIC RECURRING STUPOR - A NEW SYNDROME

      Neurology
    85. FREY KA; DESMOND T; AUGELLISZAFRAN CE; JAEN J; SCHWARZ RD
      AUTORADIOGRAPHIC DISTINCTION OF HIGH AND LOW-AFFINITY MUSCARINIC RECEPTORS BY THE M1-SELECTIVE LIGAND PD150714

      Life sciences
    86. PENNELL PB; HENRY TR; KOEPPE RA; KILBOURN MR; FREY KA
      PET IMAGING OF BENZODIAZEPINE AND MUSCARINIC RECEPTOR LOSSES IN MESIAL TEMPORAL-LOBE EPILEPSY

      Epilepsia
    87. MEYER M; KOEPPE RA; FREY KA; FOSTER NL; KUHL DE
      POSITRON EMISSION TOMOGRAPHY MEASURES OF BENZODIAZEPINE BINDING IN ALZHEIMERS-DISEASE

      Archives of neurology
    88. MURMAN DL; FREY KA; KNESPER DJ; GIORDANI B; BERENT S; KUHL DE; FOSTER NL
      CLINICAL AND NEUROPSYCHOMETRIC PREDICTORS OF PROGRESSION IN PATIENTS WITH COMPLAINTS OF MEMORY LOSS

      Annals of neurology
    89. KOLLER WC; BUSENBARK K; MINER K; ADAIR JC; AIGNER BR; ALBIN RI; ALEXANDER DN; ANTO CM; BENDER SE; BERG MJ; BERGIA BM; BLALOCK E; BURNS RS; COUCH JR; CRISOSTOMO EA; DAVIS LS; DAVIS TL; DIETRICH DW; DIMITSOPULOS TM; DOORENBOS D; ELLIS JR; ERTAG WD; FACTOR SA; FEIGIN AS; FREY KA; GADDIS KA; GIBSON GL; GOLDEN RE; GORDON MF; GREENAMYRE JT; GRIFFITH PA; GROTTA JC; HAUSER RA; HEIDEBRINK JL; HIGGINS DC; HILL SA; HILL TA; HUBBLE JP; HUTTON JT; JOHNSTON W; KIEBURTZ KD; KURLAN RM; LABUNETZ WH; LIEBERMAN AN; MAJUMDAR L; MARAGOS WF; MCCLOSKEY T; MCPHERSON SL; MILLER BR; NINO HE; OBRIEN CF; ONEILL A; OOMMEN KJ; OSBORN MA; PAHWA R; PAULSON GW; PODSKALNY GD; POOLE RM; PROTASS LM; PUGLIA JF; RICHFIELD EK; RILEY DE; SADEGHI H; SCHWARTZ H; SERANO RD; SHANNON KM; SHOULSON L; SHULMAN LM; SHULTS CW; SILVERSTEIN PM; SLEVIN JT; SNYDER RA; SOMERS AB; STACY M; SULLIVAN LP; VANHORN G; WEINER WJ; WEISS HD; WILLNER J; WILLIAMS MH; WONG GF; ZWIEBEL F
      THE RELATIONSHIP OF ESSENTIAL TREMOR TO OTHER MOVEMENT-DISORDERS - REPORT ON 678 PATIENTS

      Annals of neurology
    90. ALBIN RL; HOWLAND MM; HIGGINS DS; FREY KA
      AUTORADIOGRAPHIC QUANTIFICATION OF MUSCARINIC CHOLINERGIC SYNAPTIC MARKERS IN BAT, SHREW, AND RAT-BRAIN

      Neurochemical research
    91. LEVEY AI; EDMUNDS SM; HEILMAN CJ; DESMOND TJ; FREY KA
      LOCALIZATION OF MUSCARINIC M3 RECEPTOR PROTEIN AND M3 RECEPTOR-BINDING IN RAT-BRAIN

      Neuroscience
    92. KOEPPE RA; FREY KA; MULHOLLAND GK; KILBOURN MR; BUCK A; LEE KS; KUHL DE
      [C-11] TROPANYL BENZILATE BINDING TO MUSCARINIC CHOLINERGIC RECEPTORS- METHODOLOGY AND KINETIC MODELING ALTERNATIVES

      Journal of cerebral blood flow and metabolism
    93. BRUNBERG JA; FREY KA; HORTON JA; DEVEIKIS JP; ROSS DA; KOEPPE RA
      [O-15]H2O POSITRON EMISSION TOMOGRAPHY DETERMINATION OF CEREBRAL BLOOD-FLOW DURING BALLOON TEST OCCLUSION OF THE INTERNAL CAROTID-ARTERY

      American journal of neuroradiology
    94. MINOSHIMA S; KOEPPE RA; FREY KA; KUHL DE
      ANATOMIC STANDARDIZATION - LINEAR SCALING AND NONLINEAR WARPING OF FUNCTIONAL BRAIN IMAGES

      The Journal of nuclear medicine
    95. MINOSHIMA S; KOEPPE RA; FREY KA; ISHIHARA M; KUHL DE
      STEREOTAXIC PET ATLAS OF THE HUMAN BRAIN - AID FOR VISUAL INTERPRETATION OF FUNCTIONAL BRAIN IMAGES

      The Journal of nuclear medicine
    96. ZUBIETA JK; FREY KA; KOEPPE RA; KILBOURN MR; MULHOLLAND GK; FOSTER NL; KUHL DE
      MUSCARINIC RECEPTOR-BINDING IN AGING AND ALZHEIMERS-DISEASE DETERMINED WITH [C-11] N-METHYL-4-PIPERIDYL BENZILATE AND PET

      The Journal of nuclear medicine
    97. MINOSHIMA S; FREY KA; KOEPPE RA; MORROW TJ; KUHL DE; CASEY KL
      TEMPORAL-MODULATION OF CEREBRAL INVOLVEMENT IN PAIN PERCEPTION REVEALED BY [O-15]WATER PET IN HUMANS

      The Journal of nuclear medicine
    98. KUHL DE; FESSLER JA; MINOSHIMA S; CHO K; FREY KA; WIELAND DM; KOEPPE RA
      IN-VIVO MAPPING OF CHOLINERGIC NEURONS IN AGING AND ALZHEIMERS-DISEASE USING SPECT AND (-)-5-[I-123] IODOBENZOVESAMICOL (IBVM)

      The Journal of nuclear medicine
    99. JUNG YW; MUKHOPADHYAY S; SHERMAN PS; FREY KA; WIELAND DM
      SIGMA-RECEPTOR MAPPING

      The Journal of nuclear medicine
    100. CHO K; FREY KA; MINOSHIMA FS; ISHIHARA M; KUHL DE
      DIAGNOSTIC-CRITERIA FOR ALZHEIMERS-DISEASE BASED ON [F-18] FDG CEREBRAL METABOLIC DEFICITS

      The Journal of nuclear medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 11:27:38